With no approved vaccines to date, C. diff causes nearly 30,000 deaths each year in the US, and recurrent infections with the bacterium make up 10%-15% of all hospital-treated infections.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

A total of 501 cases of potentially fatal superbug Clostridium difficile (C diff) were notified to health officials in the first ten weeks of this year. Reports of the infection peaked in the third ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ... A new study suggests that kids who develop MIS-C (multisystem inflammatory ...

运达股份1.69% 1.30%股吧 星网锐捷1.41% 1.60%股吧 甬金股份1.39% 3.85%股吧 湖南海利1.38% 1.45%股吧 亨通光电1.37% 0.12%股吧 海星股份1.30 ...